DexCom (DXCM)
(Delayed Data from NSDQ)
$72.36 USD
+2.31 (3.30%)
Updated Aug 15, 2024 04:00 PM ET
Pre-Market: $72.18 -0.18 (-0.25%) 8:38 AM ET
4-Sell of 5 4
D Value B Growth B Momentum C VGM
Brokerage Reports
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 241 - 260 ( 415 total )
Company: DexCom, Inc.
Industry: Medical - Instruments
Q2 sales ahead of expectations, guidance range increased, maintain SELL
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Marching Toward $1 Billion in Revenue; Raising PT to $105; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Recent Trends Bode Well for Our Covered Names Reporting This Week
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
CGM Project: Historical survey of 1,664 CGM users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices - 2Q15 Preview: MedTech Underlying Fundamentals Healthy and Outlook for 2H15
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
2Q15 Preview: MedTech Underlying Fundamentals Healthy and Outlook for 2H15 Remains Positive
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices - Takeaways from J-J''s 2Q15 Results
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Q1 revenue above estimates, EPS dragged down by compensation, reiterate SELL
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Rapidly Expanding Installed Base Bodes Well For 2015; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Feltl CGM Project: Historical survey of 1,552 CGM users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Proprietary Survey Indicates DXCM''s G4 to Gain Share and CGM Technology to Experience Greater Adoption; Raising PT to $80
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
1Q15 Preview: Trends Look Better Than Initially Expected
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Takeaways from J-J''s 1Q15 Results
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices - Takeaways from J-J''s 1Q15 Results
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Proprietary Survey of Diabetes Educators Positive for Insulet and Tandem; Raising PT of PODD to $38
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
DXCM''s Quest for a Dosing Claim May Benefit from FDA''s New Expedited Access Program; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.